Core Insights - Kenvue Inc. (NYSE:KVUE) is identified as a high volume stock with potential investment interest according to Wall Street analysts [1][2] - Recent price target adjustments by major financial institutions reflect a cautious outlook for Kenvue and the broader consumer health sector [1][2] Company Overview - Kenvue operates as a consumer health company with a global presence, including regions such as the US, Europe, the Middle East, Africa, Asia-Pacific, and Latin America [3] - The company is structured into three segments: Self Care, Skin Health and Beauty, and Essential Health [3] Market Sentiment - JPMorgan has lowered Kenvue's price target to $21 from $24 while maintaining an Overweight rating, citing expected weak performance in the household and personal care group due to depressed consumer demand [1] - Citi has also reduced its price target for Kenvue to $17 from $20, keeping a Neutral rating, reflecting similar concerns about the challenging market conditions in the beverage and personal care sectors [2]